1. Arora, P., Arora, V., Lamba, H. S., & Wadhwa, D. (2012). Importance of heterocyclic chemistry: A review. Int. J. Pharm. Sci. Res., 3(9), 2947.
2. Longo Jr, L. S., & Siqueira, F. A. (2024). Synthesis of imidazo [2, 1-b] thiazol-5-amines using Groebke–Blackburn–Bienaymé multicomponent reaction (microreview). Chem Heterocycl Comp, 60(7/8),339–341.
3. Lelyukh, M. I., Komarenska, Z. M., Chaban, T. I., & Chaban, I. H. (2024). An overview of the synthetic routes toward [1, 2, 4] triazolo [3, 4-b][1, 3, 4] thiadiazoles (microreview). Chem Heterocycl Comp, 60(7/8),342–344.
4. Grinev, V. S., Demeshko, I. A., & Sklyar, A. E. (2024). The synthesis of fluorescent boron difluoride hydrazone (BODIHY) dyes (microreview). Chem Heterocycl Comp, 60(5/6),236–238.
5. Chaban, T. I., Klenina, О. V., Chaban, I. H., & Lelyukh, M. I. (2024). Recent advances in the synthesis of thiazolo [4, 5-b] pyridines. part 2: focus on thiazole annulation to pyridine ring. Chem Heterocycl Comp, 60(3/4), 130-132.
6. Chaban, T. I., Lelyukh, M. I., Chaban, I. H., & Kasyanchuk, O. Y. (2024). APPROACHES TO THE SYNTHESIS OF THIAZOLO [3, 2-a] PYRIDINES. Chem Heterocycl Comp, 60(3/4), 124-126.
7. Bondarenko, S. S., & Lega, D. A. (2024). Recent advances in the chemistry of pyrrolidine-2, 3-diones. Chem Heterocycl Comp, 60(3/4), 118-120.
8. Chandrakantha, B., Shetty, P., Nambiyar, V., Isloor, N., & Isloor, A. M. (2010). Synthesis, characterization and biological activity of some new 1, 3, 4-oxadiazole bearing 2-flouro-4-methoxy phenyl moiety. Eur. J. Med. Chem, 45(3), 1206-1210.
9. Jones, A. M., & Helm, J. M. (2009). Emerging treatments in cystic fibrosis. Drugs, 69, 1903-1910.
10. Boström, J., Hogner, A., Llinàs, A., Wellner, E., & Plowright, A. T. (2012). Oxadiazoles in medicinal chemistry. J. Med. Chem, 55(5), 1817-1830.
11. Pitasse-Santos, P., Sueth-Santiago, V., & Lima, M. E. (2018). 1,2,4 and 1,3,4-oxadiazoles as scaffolds in the development of antiparasitic agents. J. Braz. Chem. Soc., 29, 435-456.
12. Khalilullah, H., J Ahsan, M., Hedaitullah, M., Khan, S., & Ahmed, B. (2012). 1, 3, 4-oxadiazole: a biologically active scaffold. Mini-Rev. Med. Chem., 12(8), 789-801.
13. Jones, A. M., & Helm, J. M. (2009). Emerging treatments in cystic fibrosis. Drugs, 69, 1903-1910.
14. Khan, B. A., Hamdani, S. S., Khalid, M., Ashfaq, M., Munawar, K. S., Tahir, M. N., Braga. A. A. C., Shawky. A. M., Alqahtani. A. M., Abourehab. M. A. S., Gabr. G. A., Ibrahim. M. A. A., & Sidhom, P. A. (2023). Exploring probenecid derived 1, 3, 4-Oxadiazole-phthalimide hybrid as α-amylase inhibitor: Synthesis, structural investigation, and molecular modeling. J. Pharm., 16(3), 424.
15. Downing, O. A., Wilson, K. A., & Wilson, V. G. (1983). Non-competitive antagonism of the alpha-adrenoceptor-mediated fast component of contraction of rat aorta, by doxazosin and prazosin. Br. J. Pharmacol., 80(2), 315.
16. Li, Y., Liu, J., Zhang, H., Yang, X., & Liu, Z. (2006). Stereoselective synthesis and fungicidal activities of (E)-α-(methoxyimino)-benzeneacetate derivatives containing 1,3,4-oxadiazole ring. Bioorg. Med. Chem. Lett. 16(8), 2278-2282.
17. Hamada, N. M. M., & Sharshira, E. M. (2011). Synthesis and antimicrobial evaluation of some heterocyclic chalcone derivatives. Mol., 16(3), 2304-2312.
18. Loetchutinat, C., Chau, F., & Mankhetkorn, S. (2003). Synthesis and evaluation of 5-aryl-3-(4-hydroxyphenyl)-1,3,4-oxadiazole-2-(3H)-thiones as P-glycoprotein inhibitors. Chem. Pharm. Bull., 51(6), 728-730.
19. Abadi, A. H., Eissa, A. A. H., & Hassan, G. S. (2003). Synthesis of novel 1,3,4-trisubstituted pyrazole derivatives and their evaluation as antitumor and antiangiogenic agents. Chem. Pharm. Bull., 51(7), 838-844.
20. Gilani, S. J., Khan, S. A., & Siddiqui, N. (2010). Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted 1, 2, 4-triazolo-[3, 4-b]-1, 3, 4-thiadiazole and 1, 3, 4-oxadiazole derivatives of isoniazid. Bioorg. Med. Chem. Lett., 20(16), 4762-4765.
21. Mishra, L., Said, M. K., Itokawa, H., & Takeya, K. (1995). Antitumor and antimicrobial activities of Fe (II)/Fe (III) complexes derived from some heterocyclic compounds. Bioorg. Med. Chem., 3(9), 1241-1245.
22 . Zheng, Q. Z., Zhang, X. M., Xu, Y., Cheng, K., Jiao, Q. C., & Zhu, H. L. (2010). Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1, 3, 4-oxadiazole moiety as potential antitumor agents. Bioorg. Med. Chem., 18(22), 7836-7841.
23. Bankar, G. R., Nampurath, G. K., Nayak, P. G., & Bhattacharya, S. (2010). A possible correlation between the correction of endothelial dysfunction and normalization of high blood pressure levels by 1, 3, 4-oxadiazole derivative, an L-type Ca2+ channel blocker in deoxycorticosterone acetate and NG-nitro-l-arginine hypertensive rats. Chem Biol Interact, 183(2), 327-331.
24. Raman, K., Singh, H. K., Salzman, S. K., & Parmar, S. S. (1993). Substituted thiosemicarbazides and corresponding cyclized 1, 3, 4‐oxadiazoles and their anti‐inflammatory activity. J. Pharm. Sci., 82(2), 167-169.
25. Sahin, G., Palaska, E., Kelicen, P., Demirdamar, R., & Altinok, G. (2001). Synthesis of some new 1-acylthiosemicarbazides, 1, 3, 4-oxadiazoles, 1, 3, 4-thiadiazoles and l, 2, 4-triazole-3-thiones and their anti-inflammatory activities. Arzneimittelforschung, 51(06), 478-484.
26. Yale, H. L., & Losee, K. (1966). 2-Amino-5-substituted 1, 3, 4-oxadiazoles and 5-imino-2-substituted Δ2-1, 3, 4-oxadiazolines. A group of novel muscle relaxants. J. Med. Chem., 9(4), 478-483.
27. Khoramjouy, M., Zarepishe, N., Rezaee, E., Imani, A., Mahmoudzadeh-Mandolakani, R., Hashemi, S., Fallah, M., Hasheminasab, G., Shahhosseini, S., Tabatabai, S, A., & Faizi, M. (2021). Novel derivatives of diphenyl-1, 3, 4-oxadiazol as ligands of benzodiazepine receptors; synthesize, binding assay and pharmacological evaluation. Iran J Pharm Res, 20(4), 47.
28. Palmer, J. T., Hirschbein, B. L., Cheung, H., McCarter, J., Janc, J. W., Yu, Z. W., & Wesolowski, G. (2006). Keto-1, 3, 4-oxadiazoles as cathepsin K inhibitors. Bioorg. Med. Chem. Lett., 16(11), 2909-2914.
29. Johns, B. A., Weatherhead, J. G., Allen, S. H., Thompson, J. B., Garvey, E. P., Foster, S. A., Jeffrey, J, L., & Miller, W. H. (2009). The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: establishing the pharmacophore. Bioorg. Med. Chem. Lett., 19(6), 1802-1806.
30. Khan, M. T. H., Choudhary, M. I., Khan, K. M., & Rani, M. (2005). Atta-ur-rahman. structure-activity relationships of tyrosinase inhibitory combinatorial library of 2, 5-disubstituted-1, 3, 4-oxadiazole analogues. Bioorg. Med. Chem., 13(10), 3385-3395.
31 . Khamis, E., Bellucci, F., Latanision, R. M., & El-Ashry, E. S. H. (1991). Acid corrosion inhibition of nickel by 2-(triphenosphoranylidene) succinic anhydride. Corros., 47(9), 677-686.
32. Quraishi, M. A., Khan, M. A. W., Jamal, D., & Ajmal, M. (1996). Muralidharan et, S.; Iyer. J. Appl. Electrochem, 26, 1253.
33. Quraishi, M. A., Khan, M. W., Ajmal, M., Muralidharan, S., & Iyer, S. V. (1997). Technical note influence of molecular structure of substituted benzothiazoles on corrosion inhibition and hydrogen permeation through mild steel in sulphuric acid. Br. Corros. J., 32(1), 72-76.
34. Mernari, B., El Attari, H., Traisnel, M., Bentiss, F., & Lagrenee, M. (1998). Inhibiting effects of 3, 5-bis (n-pyridyl)-4-amino-1, 2, 4-triazoles on the corrosion for mild steel in 1 M HCl medium. Corros. Sci., 40(2-3), 391-399.
35. El Azhar, M., Mernari, B., Traisnel, M., Bentiss, F., & Lagrenée, M. (2001). Corrosion inhibition of mild steel by the new class of inhibitors [2, 5-bis (n-pyridyl)-1, 3, 4-thiadiazoles] in acidic media. Corros. Sci., 43(12), 2229-2238.
36. Bentiss, F., Traisnel, M., & Lagrenee, M. (2001). Influence of 2, 5-bis (4-dimethylaminophenyl)-1, 3, 4-thiadiazole on corrosion inhibition of mild steel in acidic media. J. Appl. Electrochem, 31(1), 41-48.
37. Wang, L., Yin, G. J., & Yin, J. G. (2001). 2-Mercaptothiazoline and cetyl pyridinium chloride as inhibitors for the corrosion of a low carbon steel in phosphoric acid. Corros. Sci., 43(6), 1197-1202.
38. Rochdi, A., Kassou, O., Dkhireche, N., Touir, R., El Bakri, M., Touhami, M. E., Sfairi, M., Mernari, B., & Hammouti, B. (2014). Inhibitive properties of 2, 5-bis (n-methylphenyl)-1, 3, 4-oxadiazole and biocide on corrosion, biocorrosion and scaling controls of brass in simulated cooling water. Corros. Sci., 80, 442-452.
39. Salassa, G., & Terenzi, A. (2019). Metal complexes of oxadiazole ligands: an overview. Int. J. Mol. Sci., 20(14), 3483.
40. Xu, Z., Li, Y., Ma, X., Gao, X., & Tian, H. (2008). Synthesis and properties of iridium complexes based 1, 3, 4-oxadiazoles derivatives. Tetrahedron, 64(8), 1860-1867.
41. Rasool, N., Razzaq, Z., Khan, S. G., Javaid, S., Akhtar, N., Mahmood, S., Christensen, J, B., Altaf, A, A., Anjum, S, M, M., Alqahtani, F., AlAsmari, A., & Imran, I. (2023). A facile synthesis of 1, 3, 4-oxadiazole-based carbamothioate molecules: Antiseizure potential, EEG evaluation and in-silico docking studies. Arab. J. Chem., 16(4), 104610.
42. Tolan, H. E., Fahim, A. M., & Ismael, E. H. (2023). Synthesis, biological activities, molecular docking, theoretical calculations of some 1, 3, 4-oxadiazoles, 1, 2, 4-triazoles, and 1, 2, 4-triazolo [3, 4-b]-1, 3, 4-thiadiazines derivatives. J. Mol. Struct., 1283, 135238.
43. Fan, C., Chen, J., Xu, Z., Yin, P., Wu, C., & Sun, T. (2024). Synthesis, crystal structure, anti-tuberculosis activity and toxicity prediction of N-(4-bromophenyl)-3-(5-(4-chloro-3-nitrophenyl)-1, 3, 4-oxadiazol-2-yl) benzenesulfonamide. J. Mol. Struct., 1297, 136901.
44. Alzahrani, A. Y. A., Ullah, H., Bhat, M. A., Rahim, F., Al-Wesabi, E. O., & Alanazi, T. Y. (2024). Design, synthesis, in vitro acetylcholinesterase, butyrylcholinesterase activities, and in silico molecular docking study of oxindole-oxadiazole hybrid analogues. J. Mol. Struct., 1299, 137167.
45. Thongolla, R., Pulabala, R., Gogula, S. S., Shenoy, T. N., Salam, A. A. A., Vankadari, S. R., Rondla, R., & Puchakayala, M. R. (2024). Design, synthesis, and molecular docking studies of new phenanthrene-linked oxadiazoles as potential antimicrobial agents. J. Mol. Struct., 1300, 137260.
46. Bhukta, S., Chatterjee, R., Angajala, K. K., & Dandela, R. (2023). Iodine-mediated domino cyclization of hydrazides for one-pot synthesis of 1, 3, 4-oxadiazoles via oxidative bond cleavage of vinyl azide. TETL, 128, 154714.
47. Doddagaddavalli, M. A., Kalalbandi, V. K. A., Seetharamappa, J., & Joshi, S. D. (2024). New thiophene-1, 3, 4-oxadiazole-thiazolidine-2, 4-dione hybrids: dynthesis, MCF-7 inhibition and binding studies. Bioorg. Chem., 143, 107003.
48. Peng, J., Zhang, Y., Liu, X., Zou, Y., Song, H., Wang, S., Cai, Q., Chen, J., & Hu, D. (2023). Design, synthesis, antibacterial activity, and mechanism of novel resveratrol derivatives containing an 1, 3, 4-oxadiazole moiety. Pestic Biochem Physiol., 193, 105457.
49. Xie, W., & Li, L. (2024). Preparation and properties of modified POD membranes by polycarboxylic acids copolymerization. React. Funct. Polym., 105829.
50. Gastaldi, S., Rocca, C., Gianquinto, E., Granieri, M. C., Boscaro, V., Blua, F & Angelone, T. (2023). Discovery of a novel 1, 3, 4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation. Eur. J. Med. Chem., 115542.
51. Hossan, A., Abumelha, H. M., Alnoman, R. B., Bayazeed, A., Alsoliemy, A., Keshk, A. A., & El-Metwaly, N. M. (2022). Synthesis, self-assembly and optical properties of novel fluorescent alkoxy-substituted fluoroaryl 1, 3, 4-oxadiazole organogelator. Arab. J. Chem., 15(5), 103771.
52. Kumar, P. B. R., Kadiri, S. K., Khobragade, D. S., Priya, R. V., Veni, C. K., Srilakshmi, S., & Tiwari, P. (2024). Synthesis, characterization and biological investigations of some new Oxadiazoles: In-vitro and In-Silico approach. Results Chem., 7, 101241.
53. Bisht, A. S., & Juyal, D. (2024). Synthesis and bioactive investigation of amino acids fused 1, 3, 4-oxadiazole derivatives as unnatural amino Acids. Ind. J. Pharm. Edu. Res, 58(1), 1-6.
54. Mahanty, K., Halder, A., & De Sarkar, S. (2023). Synthesis of N‐sulfonyl amidines and 1, 3, 4‐oxadiazoles through electrochemical activation of DMF. Adv. Synth. Catal., 365(1), 96-103.
55. König, B., Watson, P. R., Reßing, N., Cragin, A. D., Schäker-Hübner, L., Christianson, D. W., & Hansen, F. K. (2023). Difluoromethyl-1, 3, 4-oxadiazoles are selective, mechanism-based, and essentially irreversible inhibitors of histone deacetylase 6. J. Med. Chem., 66(19), 13821-13837.
56. Lachhab, S., Oubella, A., Mehdi, A., Neyts, J., Jochmans, D., Chiu, W., Vangeel, L., Jonghe, S, D., Morjani, H., Ali, M, A., Zanouily, M., Sanghvi, Y, S., & Lazrek, H. B. (2023). Synthesis, characterization, molecular docking, and anticancer activities of new 1, 3, 4-oxadiazole-5-fluorocytosine hybrid derivatives. J. Mol. Struct.1272, 134135.
57. Hashem, H. E., Ahmad, S., Kumer, A., & Bakri, Y. E. (2024). In silico and in vitro prediction of new synthesized N-heterocyclic compounds as anti-SARS-CoV-2. Sci. Rep., 14(1), 1152.
58. He, S., Wang, C., Cheng, Z., Li, X., Si, Z., Huang, Y., Chen, L., & Zhang, Y. (2024). Synthesis and application of dithiocarbamate oxadiazole thione for flotation separation of malachite from quartz and calcite. Adv. Powder Technol., 35(1), 104315.
59. Alaasar, M., Darweesh, A. F., Cao, Y., Iakoubovskii, K., & Yoshio, M. (2024). Electric field-and light-responsive oxadiazole bent-core polycatenar liquid crystals. J. Mater. Chem. C, 12(4), 1523-1532.
60. Lu, A., Zheng, Y., Li, T., Wang, J., & Song, G. (2024). Structural diversity derivatization and studies on the nematicidal activity of tropane derivatives. Phytochem. Lett., 59, 108-116.
61. Bhandari, S. V., Nagras, O. G., Kuthe, P. V., Sarkate, A. P., Waghamare, K. S., Pansare, D. N., Chaudhari, S, Y., Mawale, S, N., & Belwate, M. C. (2023). Design, synthesis, molecular docking and antioxidant avaluation of benzimidazole-1, 3, 4 oxadiazole derivatives. J. Mol. Struct., 1276, 134747.
62. Balogh, R., Eckstein, A., Tokár, K., & Danko, M. (2023). The synthesis and spectral study of thiazolo [5, 4-d] thiazole based small molecules using 1, 3, 4-oxadiazole as a linker for organic electronics. J Photochem Photobiol A Chem, 434, 114217.
63. Oliveira, M. S., Santos, A. B., Ferraz, T. V., Moura, G. L., & Falcão, E. H. (2023). Non-symmetrical 1, 3, 4-oxadiazole derivatives: synthesis, characterization, and computational study of their optical properties. Chem. Phys. Impact, 6, 100162.
64. Pflégr, V., Stolaříková, J., Pál, A., Korduláková, J., & Krátký, M. (2023). Novel pyrimidine-1, 3, 4-oxadiazole hybrids and their precursors as potential antimycobacterial agents. Future Med. Chem., 15(12), 1049-1067.
65. Zheng, X., Yan, T., Cheng, G., & Yang, H. (2023). An advanced zwitterionic compound based on dinitropyrazole and 1, 3, 4-oxadiazole: combining the high detonation performances and low sensitivities. J. Chem. Eng., 460, 141654.
66. Verdoorn, D. S., Ranjan, P., De Reuver, T., Janssen, E., Vande Velde, C. M., Saya, J. M., Maes, B, U., & Orru, R. V. (2023). A Cobalt mediated nitrene transfer aza-wittig cascade reaction to access 1, 3, 4-oxadiazole scaffolds. Org. Lett., 25(22), 4005-4009.
67. Alharthi, A. I., Alotaibi, M. A., AbdelFattah, E., Akela, M. A., Ali, I., Nassar, A. A., & Bakht, M. A. (2023). Facile catalytic construction of one-pot two-component 1, 3, 4-oxadiazole derivatives over Zn promoted Cu/CeO3 catalysts in semi-aqueous condition. J. Mol. Struct., 1291, 136004.
68. Meng, H. W., Shen, Z. B., Meng, X. S., Yin, Z. Q., Wang, X. R., Zou, T. F., Liu, Z, G., Wang, T, X., Zhang, S., Chen, Y, L., Yang, X, X., Li, Q, S., & Duan, Y. J. (2023). Novel flavonoid 1, 3, 4-oxadiazole derivatives ameliorate MPTP-induced parkinson's disease via Nrf2/NF-κB signaling pathway.
Bioorg. Chem., 106654.
69. Karabelyov, V., Angelova, V. T., Sharkov, M., Mihaylova, R., Popov, G., Pencheva, T., Manov, V., Dangalov, M., Todorova, N., & Kondeva-Burdina, M. (2023). In vitro/in vivo effects of some new 2, 5-disubstituted 1, 3, 4-oxadiazole and hydrazone analogues targeting Parkinson's disease. J. Mol. Struct., 1288, 135755.
70. Rezaee, E., Ahmadi, F., Shabaninia, M., Khoramjouy, M., Farsani, Z. A., Shahhosseini, S., Tabatabai, S, A., & Faizi, M. (2023). Novel 2-substituted-5-(4-chloro-2-phenoxy) phenyl-1, 3, 4-oxadiazole derivatives, ligands of GABAA/benzodiazepine receptor complex: design, synthesis, radioligand binding assay, and pharmacological evaluation. EXCLI J., 22,
71. Maruthesh, H., Katagi, M. S., Samuel, J., Aladakatti, R. H., & Nandeshwarappa, B. P. (2023). Synthesis and characterization of substituted 5-(2-Chloroquinolin-3-yl)-1, 3, 4-oxadiazole-2-amines: computational, in silico ADME, molecular docking, and biological activities. Russ. J. Bioorg. Chem., 49(6), 1422-1437.
72. Syeda, A. B., Ferazoddin, M., Rajeswari, M., Paul, J. P., & Juluru, B. (2023). Design, synthesis and anticancer evaluation of benzoxazole resemble substituted arylamide derivatives of bis-1, 3, 4-oxadiazole-oxazolo [4, 5-b] pyridin-2-yl) as anticancer agents. Chem. Data Collect., 43, 100971.
73. Naik, L., Thippeswamy, M. S., Praveenkumar, V., Malimath, G. H., Ramesh, D., Sutar, S., Savanur, H, M., Gudennavar, S, B., & Bubbly, S. G. (2023). Solute-solvent interaction and DFT studies on bromonaphthofuran 1, 3, 4-oxadiazole fluorophores for optoelectronic applications. J. Mol. Graph. Model. 118, 108367.
74. Caputo, F., Corbetta, S., Piccolo, O., & Vigo, D. (2020). Seeking for selectivity and efficiency: new approaches in the synthesis of raltegravir. Org. Process Res. Dev., 24(6), 1149-1156.
75. Karabanovich, G., Zemanová, J., Smutný, T., Székely, R., Šarkan, M., Centárová, I., Vocat, A., Pavkova, I., Conka, P., Nemecek, J., Stolarikova, J., Vejsova, M., Vavrova, K., Klimesova, V., Hrabalek, A., Pavek, P., Cole, S, T., Mikusova, K., & Roh, J. (2016). Development of 3, 5-dinitrobenzylsulfanyl-1, 3, 4-oxadiazoles and thiadiazoles as selective antitubercular agents active against replicating and nonreplicating Mycobacterium tuberculosis. J. Med. Chem., 59(6), 2362-2380